AI赋能医药研发路演专场

14:00 - 16:50
  • 主持人 Moderator
  • 杨烨辉, 华金证券产业投行部总经理
  • YANG Yehui, General Manager of Industry Investment Banking Department, HuaJin Securities
  • 交流嘉宾 Invited Discussants:
  • 朱畴文, 上海临床研究中心主任(院长)
  • ZHU Chouwen, Director (President), Shanghai Clinical Research Center
  • 邱婧君, 复星医药AI专委会联席主任、创新药事业部高级副总裁
  • Jeannie QIU, Co-Chair, Fosun Pharma AI Innovation Committee; SVP, Innovative Medicine BU; GM, AI and Digital Intelligence; GM, Biometrics and Data Science
  • 杨烨辉, 华金证券产业投行部总经理
  • YANG Yehui, General Manager of Industry Investment Banking Department, HuaJin Securities
14:00 - 14:20
  • 主题报告
  • Keynote Speech
  • AI for Science医药:假说免费、验证定价,全球和中国资产价值链分解
  • AI for Science in Pharmaceuticals: Hypothesis-Free, Validation-Priced, Value Chain Breakdown of Global and Chinese Assets
  • 谭国超, 华安证券副所长、医药首席分析师
  • TAN Guochao, Deputy Director & Chief Analyst of Pharmaceutical Industry of Huaan Securities Research Institute
14:20 - 14:45
  • 项目1
  • Project 1
  • 数据智能驱动新药研发:自研AI药研智能体平台
  • Data - Intelligence Driven New Drug R&D: Self ‑developed AI Drug‑Research Agent Platform
  • 邹彬彬, 广州医药数智科技有限公司董事长
  • ZOU Binbin, Chairman, Guangzhou Pharma Digital Intelligence Tech. Co., Ltd.
14:45 - 15:10
  • 项目2
  • Project 2
  • CP-GFM-SGX:面向难成药PPI靶点的AI环肽研发工业引擎
  • CP-GFM-SGX: A Cyclic Peptide Discovery Engine for Challenging PPI Targets
  • 胡智渊, 北京深智序元生物科技有限公司总经理
  • HU Zhiyuan, CEO of Beijing Deep Intelligent Sequence Origin Biotechnology Co., Ltd.
15:10 - 15:35
  • 项目3
  • Project 3
  • AI驱动的分子创制药物开发平台
  • An Al-Driven Molecular Creation Drug Development Platform
  • 于永明, 瀛玑智药(北京)科技有限公司总经理
  • YU Yongming, General Manager, Yingji Zhiyao (Beijing) Technology Co., Ltd.
15:35 - 16:00
  • 项目4
  • Project 4
  • AI驱动的多肽药物发现:从10⁶⁰级化学空间到药物资产
  • From 10⁶⁰ Chemical Space to Drug Assets: AI-Driven Peptide Drug Discovery
  • 黄茜丹, Space Generate亚太区总裁
  • Sandy HUANG, President of APAC, Space Generate
16:00 - 16:25
  • 项目5
  • Project 5
  • AI+疾病表型平台赋能脑疾病药物发现
  • AI-Driven Disease Phenotyping Platform Empowers Brain- Disease Drug Discovery
  • 任俊名, 泰康诺生物科技有限公司项目负责人
  • REN Junming, Project Lead of Taikangnuo Biotechnology Co., Ltd.
16:25 - 16:50
  • 项目6
  • Project 6
  • Twist Bioscience赋能AI药物发现:从数字化序列合成到可用于模型训练的实验数据
  • Twist Bioscience x AIDD: From Sequences to Dataset
  • 言野, 拓唯思特生物科技(中国)有限公司现场应用科学家团队经理
  • YAN Ye, Manager, Field Application Scientist,Twist Bioscience Corporation
16:50 - 17:15
  • 项目7
  • Project 7
  • 基于AI和RNA分子结构的药物设计与产能优化科技服务
  • Integrated Technology Services for AI-and RNA Structure-driven Drug Design and Production Capacity Optimization
  • 吴弘, 上海月新生科信息科技有限公司创始人
  • WU Hong, Founder of Biotunnel Co., Ltd.